Where CareDx Stands With Analysts
Portfolio Pulse from Benzinga Insights
CareDx (NASDAQ:CDNA) has received diverse ratings from 6 analysts over the past three months, with 5 being bullish and 1 somewhat bullish. The average 12-month price target has increased to $16.67, reflecting a 26.29% rise from the previous target. Analysts from firms like Goldman Sachs and Craig-Hallum have raised their price targets, indicating positive sentiment despite recent revenue declines.
July 17, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
CareDx has received predominantly bullish ratings from analysts, with an average 12-month price target of $16.67, up 26.29% from the previous target. Analysts from Goldman Sachs and Craig-Hallum have raised their price targets, reflecting positive sentiment despite a recent decline in revenue growth.
The majority of analysts have given bullish ratings, and the average price target has increased significantly. This indicates strong positive sentiment towards CareDx, which is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100